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A 55-year-old woman presented with frequent episodes of syncope due to sinus 
pauses. During ambulatory Holter monitoring, atrial fibrillation and first-degree 
atrioventricular nodal block were observed. Magnetic resonance imaging and CT 
scans showed a tumor-like mass from the superior vena cava to the right atrial sep-
tum. Open chest cardiac biopsy was performed. The tumor was composed of pro-
liferating IgG4-positive plasma cells and lymphocytes with surrounding sclerosis. 
The patient was diagnosed with IgG4-related sclerosing disease. Because of fre-
quent sinus pauses and syncope, a permanent pacemaker was implanted. The car-
diac mass was inoperable, but it did not progress during the one-year follow-up. 
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INTRODUCTION
IgG4-related sclerosing disease is a systemic disease characterized by extensive 
IgG4-positive plasma cells and T-lymphocyte infiltration of various organs. Hama-
no, et al.1 reported that patients with sclerosing pancreatitis had a high serum IgG4 
concentration with abundant and diffuse infiltration of IgG4-positive plasma cells 
in the pancreas. Since that original report, abundant IgG4-positive plasma cell in-
filtrates have been demonstrated in many extrapancreatic sclerotic lesions.2 In-
volvement of the heart in IgG4-related sclerosing disease is rare.3 The clinical pre-
sentation depends on the involved tissues; however, the histopathologic findings 
seem to be similar regardless of location.4 We report a case of IgG4-related scle-
rosing disease involving cardiac conduction system, that induced recurrent synco-
pe in a middle aged female patient. 
CASE REPORT
A 55-year-old woman was admitted to our institution with recurrent episodes of 
syncope and dizziness. She had no underlying disease, including autoimmune dis-
eases. The patient’s past medical history was not significant for any medications or 
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ry Holter monitoring, frequent episodes of sinus pauses and 
atrial fibrillation were observed. 
Transthoracic echocardiography and magnetic resonance 
imaging demonstrated a mass extending from the superior 
venacava (SVC)-right atrium (RA) junction to the right 
atrium posterior wall and interatrial septum (Fig. 2Aa). Flu-
orodeoxyglucose positron emission tomography showed 
increased uptake in a mass involving the RA wall and inter-
atrial septum (Fig. 2Ab). No other evidence of abnormal 
uptake was noted. Transcutaneous cardiac biopsy was per-
formed, however, failed to obtain enough tissue to confirm 
the histologic diagnosis. Therefore, the patient underwent 
open chest biopsy. Histologically, the lesion was composed 
of proliferating IgG4-positive plasma cells and lympho-
cytes (Fig. 3). The ratio of IgG4/IgG positive cells was 
68% in average. And absolute number of IgG4-positive 
cells was approximate 146.5 per high-power field in the 
hottest area. These findings are consistent with IgG4-relat-
ed sclerosing disease.2
The cardiac mass involved the SVC and interatrial sep-
illicit drugs. The electrocardiogram on admission showed 
first-degree atrioventricular block with a prolonged PR in-
terval of 240 ms (Fig. 1A). Furthermore, the patient dem-
onstrated atrial fibrillation (Fig. 1B) and a sinus pause of six 
seconds during an exercise test (Fig. 1C). During ambulato-
Fig. 1. (A) ECG taken on admission. First-degree AV block was observed 
with a PR interval of 240 ms. (B) Recovery phase during an exercise test. 
(C) Note the six-second sinus pause that was associated with dizziness. 
ECG, electrocardiogram; AV, atrioventricular.
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Fig. 2. (Aa) Heart MRI showing a low-density mass lesion from the SVC and RA junction (left panel) to the right atrium of the heart (right 
panel). (Ab and Ac) Positron emission tomography-computed tomography showing increased FDG uptake at the SVC-RA junction and in-
terartrial septum. (B) Heart multidetector computed tomography taken one year after diagnosis. No remarkable change of the mass. SVC, 
superior venacava; RA, right atrium; FDG, fluorodeoxyglucose.
IgG4-Related Sclerosing Disease Involving the Heart
Yonsei Med J   http://www.eymj.org   Volume 54   Number 5   September 2013 1287
ever, to our knowledge, involvement of the cardiac conduc-
tion system has not been reported.
The cause and clinical progress of IgG4-related sclerosing 
disease remain undefined. Some studies report a rapidly fatal 
outcome of this disease.8 As the cause is unknown, there is 
no consensus on the optimal treatment approach. IgG4-relat-
ed sclerosing disease has previously been suggested to be 
managed by corticosteroid and/or immunosuppressive thera-
pies.9-11 In this case, we did not perform chemotherapy or 
corticosteroid therapy because of patient refusal. Instead, the 
patient’s symptoms were managed by pacemaker implanta-
tion. Interestingly, tumor progression was not observed dur-
ing a one-year follow-up period. Although the follow-up 
duration was short, we suggest that symptomatic manage-
ment alone might be a possible option for treatment of this 
disease.
In summary, there has been no case in the literature of in-
tracardiac IgG4-related sclerosing disease that involves the 
sinus and atrioventricular nodes. Our report suggests that 
IgG4-related sclerosing disease has a favorable prognosis 
tum, and was inoperable. Additional chemotherapy or ste-
roid therapy was not performed because of patient’s prefer-
ence. A permanent VVI-type pacemaker was implanted due 
to frequent sinus pauses and syncope. During a one-year 
follow-up, the patient had no additional episodes of synco-
pe, and the mass showed no evidence of progression (Fig 
2Ac and B). 
DISCUSSION
IgG4-related sclerosing disease is a relatively newly found 
entity with distinct clinicopathologic characteristics. The dis-
ease was originally discovered in patients with autoimmune 
pancreatitis and an elevated serum level of IgG4. It is charac-
terized by extensive IgG4-positive plasma cells and T lym-
phocyte infiltration of various organs. Cardiac involvement 
of this disease is extremely rare. Recent reports described 
cardiovascular IgG4-related sclerosing disease as pericardi-
tis and periarteritis related to heart failure or angina.5-7 How-
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Fig. 3. (A) Low-power view showing multifocal vague lymphoid follicle formations (H-E ×40). (B) High-power view showing dense extensive lymphoplasma-
cytic infiltrations (H-E ×200). (C) IgG4 immunohistochemical staining shows many positive plasma cells (IgG4, ×100). (D and E) More than 50 IgG4-positive 
plasma cells are observed (D, IgG4 ×400). The ratio of IgG4/IgG positive cells is greater than 40% (E, IgG ×400). (F) Trichrome staining does not show marked-
ly abundant collagen deposition. (G and H) The immunohistochemical staining for CD20 and CD3 reveals a lot of T cell infiltration, mainly in paracortical area.
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and withhold steroid therapy. If there is no deterioration of 
symptoms, symptomatic management and regular follow-
up might be a reasonable treatment option.
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